Essex Investment Management CO LLC Chembio Diagnostics, Inc. Transaction History

Essex Investment Management CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 04, 2020	SELL	$3.18 - $15.54 $439,094 - $2.15 Million	-138,080 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$2.36 - $5.6 $17,348 - $41,165	-7,351 Reduced 5.05%	138,080 $707,000
Q4 2019 Feb 10, 2020	BUY	$3.94 - $5.76 $26,902 - $39,329	6,828 Added 4.93%	145,431 $663,000
Q3 2019 Oct 22, 2019	SELL	$4.84 - $7.25 $76,491 - $114,579	-15,804 Reduced 10.24%	138,603 $848,000
Q2 2019 Aug 15, 2019	BUY	$5.56 - $7.85 $858,502 - $1.21 Million	154,407 New	154,407 $940,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.